nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—NPR1—endothelium—melanoma	0.0272	0.0872	CbGeAlD
Nitroglycerin—NPR1—blood vessel—melanoma	0.0251	0.0804	CbGeAlD
Nitroglycerin—ALDH2—hair follicle—melanoma	0.0243	0.0778	CbGeAlD
Nitroglycerin—Rash generalised—Vemurafenib—melanoma	0.0236	0.0482	CcSEcCtD
Nitroglycerin—Paralysis—Vemurafenib—melanoma	0.0145	0.0295	CcSEcCtD
Nitroglycerin—GUCY1A3—eye—melanoma	0.0144	0.0461	CbGeAlD
Nitroglycerin—GUCY1B3—eye—melanoma	0.0143	0.0457	CbGeAlD
Nitroglycerin—GUCY1A3—retina—melanoma	0.0142	0.0457	CbGeAlD
Nitroglycerin—GUCY1B3—retina—melanoma	0.0141	0.0453	CbGeAlD
Nitroglycerin—Angina unstable—Docetaxel—melanoma	0.0135	0.0275	CcSEcCtD
Nitroglycerin—Diarrhoea haemorrhagic—Docetaxel—melanoma	0.0135	0.0275	CcSEcCtD
Nitroglycerin—NPR1—eye—melanoma	0.0133	0.0428	CbGeAlD
Nitroglycerin—NPR1—retina—melanoma	0.0132	0.0424	CbGeAlD
Nitroglycerin—GUCY1A2—head—melanoma	0.013	0.0415	CbGeAlD
Nitroglycerin—Intracranial pressure increased—Carmustine—melanoma	0.0127	0.0259	CcSEcCtD
Nitroglycerin—ALDH2—eye—melanoma	0.0121	0.0388	CbGeAlD
Nitroglycerin—ALDH2—retina—melanoma	0.012	0.0385	CbGeAlD
Nitroglycerin—GUCY1A3—mammalian vulva—melanoma	0.0114	0.0366	CbGeAlD
Nitroglycerin—GUCY1B3—mammalian vulva—melanoma	0.0113	0.0363	CbGeAlD
Nitroglycerin—Cerebral ischaemia—Temozolomide—melanoma	0.0106	0.0216	CcSEcCtD
Nitroglycerin—NPR1—mammalian vulva—melanoma	0.0106	0.0339	CbGeAlD
Nitroglycerin—ALDH2—skin of body—melanoma	0.0105	0.0338	CbGeAlD
Nitroglycerin—ALDH2—mammalian vulva—melanoma	0.00961	0.0308	CbGeAlD
Nitroglycerin—GUCY1A2—lymph node—melanoma	0.00907	0.0291	CbGeAlD
Nitroglycerin—GUCY1A3—head—melanoma	0.00816	0.0262	CbGeAlD
Nitroglycerin—GUCY1B3—head—melanoma	0.0081	0.026	CbGeAlD
Nitroglycerin—Rash generalised—Docetaxel—melanoma	0.00803	0.0164	CcSEcCtD
Nitroglycerin—Burning sensation—Carmustine—melanoma	0.00764	0.0156	CcSEcCtD
Nitroglycerin—NPR1—head—melanoma	0.00757	0.0243	CbGeAlD
Nitroglycerin—ALDH2—head—melanoma	0.00688	0.022	CbGeAlD
Nitroglycerin—GUCY1B3—Nitric oxide stimulates guanylate cyclase—NOS2—melanoma	0.00666	0.0337	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Nitric oxide stimulates guanylate cyclase—NOS2—melanoma	0.00666	0.0337	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Nitric oxide stimulates guanylate cyclase—NOS2—melanoma	0.00594	0.03	CbGpPWpGaD
Nitroglycerin—GUCY1A3—lymph node—melanoma	0.00571	0.0183	CbGeAlD
Nitroglycerin—GUCY1B3—lymph node—melanoma	0.00567	0.0182	CbGeAlD
Nitroglycerin—Infestation NOS—Vemurafenib—melanoma	0.00562	0.0115	CcSEcCtD
Nitroglycerin—Infestation—Vemurafenib—melanoma	0.00562	0.0115	CcSEcCtD
Nitroglycerin—NPR1—lymph node—melanoma	0.0053	0.017	CbGeAlD
Nitroglycerin—Redness—Docetaxel—melanoma	0.00505	0.0103	CcSEcCtD
Nitroglycerin—Oedema peripheral—Vemurafenib—melanoma	0.00497	0.0101	CcSEcCtD
Nitroglycerin—Burning sensation—Docetaxel—melanoma	0.00491	0.01	CcSEcCtD
Nitroglycerin—Coma—Carmustine—melanoma	0.00485	0.00989	CcSEcCtD
Nitroglycerin—ALDH2—lymph node—melanoma	0.00481	0.0154	CbGeAlD
Nitroglycerin—Cardiac disorder—Vemurafenib—melanoma	0.00468	0.00954	CcSEcCtD
Nitroglycerin—Dermatitis atopic—Docetaxel—melanoma	0.00461	0.0094	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—UGT2B10—melanoma	0.00461	0.0233	CbGpPWpGaD
Nitroglycerin—Angiopathy—Vemurafenib—melanoma	0.00457	0.00933	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Vemurafenib—melanoma	0.00454	0.00927	CcSEcCtD
Nitroglycerin—Erythema—Vemurafenib—melanoma	0.00439	0.00895	CcSEcCtD
Nitroglycerin—Hot flush—Temozolomide—melanoma	0.00398	0.00812	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Temozolomide—melanoma	0.00395	0.00805	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Temozolomide—melanoma	0.00395	0.00805	CcSEcCtD
Nitroglycerin—Chest discomfort—Docetaxel—melanoma	0.00386	0.00786	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00371	0.00757	CcSEcCtD
Nitroglycerin—ALDH2—Tryptophan metabolism—CYP1B1—melanoma	0.00371	0.0188	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—CEACAM1—melanoma	0.0037	0.0187	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CEACAM1—melanoma	0.0037	0.0187	CbGpPWpGaD
Nitroglycerin—Anaphylactic shock—Vemurafenib—melanoma	0.00358	0.0073	CcSEcCtD
Nitroglycerin—Infection—Vemurafenib—melanoma	0.00356	0.00726	CcSEcCtD
Nitroglycerin—Nervous system disorder—Vemurafenib—melanoma	0.00351	0.00716	CcSEcCtD
Nitroglycerin—Skin disorder—Vemurafenib—melanoma	0.00348	0.00709	CcSEcCtD
Nitroglycerin—Hypotension—Vemurafenib—melanoma	0.00335	0.00682	CcSEcCtD
Nitroglycerin—Stomatitis—Bleomycin—melanoma	0.00332	0.00676	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—CEACAM1—melanoma	0.0033	0.0167	CbGpPWpGaD
Nitroglycerin—Sweating increased—Temozolomide—melanoma	0.00314	0.00639	CcSEcCtD
Nitroglycerin—Stomatitis—Dactinomycin—melanoma	0.00309	0.00631	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Vemurafenib—melanoma	0.00309	0.00631	CcSEcCtD
Nitroglycerin—Lightheadedness—Docetaxel—melanoma	0.00305	0.00623	CcSEcCtD
Nitroglycerin—Stomatitis—Carmustine—melanoma	0.0029	0.0059	CcSEcCtD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.00289	0.0146	CbGpPWpGaD
Nitroglycerin—Infestation NOS—Temozolomide—melanoma	0.00287	0.00585	CcSEcCtD
Nitroglycerin—Infestation—Temozolomide—melanoma	0.00287	0.00585	CcSEcCtD
Nitroglycerin—Flushing—Bleomycin—melanoma	0.00283	0.00578	CcSEcCtD
Nitroglycerin—Body temperature increased—Vemurafenib—melanoma	0.00283	0.00577	CcSEcCtD
Nitroglycerin—Pharyngitis—Dactinomycin—melanoma	0.00283	0.00577	CcSEcCtD
Nitroglycerin—Stomatitis—Temozolomide—melanoma	0.0028	0.0057	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—SLC6A11—melanoma	0.0027	0.0137	CbGpPWpGaD
Nitroglycerin—Erythema—Bleomycin—melanoma	0.00266	0.00542	CcSEcCtD
Nitroglycerin—Hot flush—Docetaxel—melanoma	0.00265	0.0054	CcSEcCtD
Nitroglycerin—Flushing—Dactinomycin—melanoma	0.00264	0.00539	CcSEcCtD
Nitroglycerin—Hypersensitivity—Vemurafenib—melanoma	0.00264	0.00538	CcSEcCtD
Nitroglycerin—Oedema peripheral—Carmustine—melanoma	0.00263	0.00536	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Docetaxel—melanoma	0.00262	0.00535	CcSEcCtD
Nitroglycerin—Visual disturbance—Docetaxel—melanoma	0.00261	0.00533	CcSEcCtD
Nitroglycerin—GUCY1A2—Platelet homeostasis—NOS2—melanoma	0.0026	0.0131	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Platelet homeostasis—NOS2—melanoma	0.0026	0.0131	CbGpPWpGaD
Nitroglycerin—Asthenia—Vemurafenib—melanoma	0.00257	0.00524	CcSEcCtD
Nitroglycerin—Visual impairment—Carmustine—melanoma	0.00257	0.00524	CcSEcCtD
Nitroglycerin—Pharyngitis—Temozolomide—melanoma	0.00256	0.00521	CcSEcCtD
Nitroglycerin—Oedema peripheral—Temozolomide—melanoma	0.00254	0.00518	CcSEcCtD
Nitroglycerin—Pruritus—Vemurafenib—melanoma	0.00253	0.00517	CcSEcCtD
Nitroglycerin—Visual impairment—Temozolomide—melanoma	0.00248	0.00506	CcSEcCtD
Nitroglycerin—Erythema—Dactinomycin—melanoma	0.00248	0.00506	CcSEcCtD
Nitroglycerin—Flushing—Carmustine—melanoma	0.00247	0.00505	CcSEcCtD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.00243	0.0123	CbGpPWpGaD
Nitroglycerin—Flushing—Temozolomide—melanoma	0.00239	0.00488	CcSEcCtD
Nitroglycerin—Cardiac disorder—Temozolomide—melanoma	0.00239	0.00488	CcSEcCtD
Nitroglycerin—Arrhythmia—Carmustine—melanoma	0.00238	0.00486	CcSEcCtD
Nitroglycerin—Dizziness—Vemurafenib—melanoma	0.00237	0.00483	CcSEcCtD
Nitroglycerin—Angiopathy—Temozolomide—melanoma	0.00234	0.00477	CcSEcCtD
Nitroglycerin—Mental disorder—Carmustine—melanoma	0.00234	0.00476	CcSEcCtD
Nitroglycerin—Immune system disorder—Temozolomide—melanoma	0.00233	0.00475	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Temozolomide—melanoma	0.00232	0.00474	CcSEcCtD
Nitroglycerin—Erythema—Carmustine—melanoma	0.00232	0.00473	CcSEcCtD
Nitroglycerin—GUCY1A3—Platelet homeostasis—NOS2—melanoma	0.00231	0.0117	CbGpPWpGaD
Nitroglycerin—Vomiting—Vemurafenib—melanoma	0.00228	0.00464	CcSEcCtD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—GNAQ—melanoma	0.00227	0.0115	CbGpPWpGaD
Nitroglycerin—Orthostatic hypotension—Docetaxel—melanoma	0.00226	0.00461	CcSEcCtD
Nitroglycerin—Rash—Vemurafenib—melanoma	0.00226	0.00461	CcSEcCtD
Nitroglycerin—Mental disorder—Temozolomide—melanoma	0.00226	0.0046	CcSEcCtD
Nitroglycerin—Dermatitis—Vemurafenib—melanoma	0.00226	0.0046	CcSEcCtD
Nitroglycerin—Headache—Vemurafenib—melanoma	0.00224	0.00458	CcSEcCtD
Nitroglycerin—Erythema—Temozolomide—melanoma	0.00224	0.00457	CcSEcCtD
Nitroglycerin—Confusional state—Bleomycin—melanoma	0.00219	0.00446	CcSEcCtD
Nitroglycerin—Vision blurred—Carmustine—melanoma	0.00219	0.00446	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Bleomycin—melanoma	0.00217	0.00443	CcSEcCtD
Nitroglycerin—Infection—Bleomycin—melanoma	0.00216	0.0044	CcSEcCtD
Nitroglycerin—Agitation—Carmustine—melanoma	0.00213	0.00435	CcSEcCtD
Nitroglycerin—Nausea—Vemurafenib—melanoma	0.00213	0.00434	CcSEcCtD
Nitroglycerin—Vision blurred—Temozolomide—melanoma	0.00211	0.00431	CcSEcCtD
Nitroglycerin—Angina pectoris—Docetaxel—melanoma	0.00209	0.00425	CcSEcCtD
Nitroglycerin—ALDH2—Neuronal System—SLC6A11—melanoma	0.00207	0.0105	CbGpPWpGaD
Nitroglycerin—Agitation—Temozolomide—melanoma	0.00206	0.0042	CcSEcCtD
Nitroglycerin—Angioedema—Temozolomide—melanoma	0.00205	0.00418	CcSEcCtD
Nitroglycerin—Hypotension—Bleomycin—melanoma	0.00203	0.00413	CcSEcCtD
Nitroglycerin—Vertigo—Temozolomide—melanoma	0.00202	0.00411	CcSEcCtD
Nitroglycerin—Infection—Dactinomycin—melanoma	0.00201	0.0041	CcSEcCtD
Nitroglycerin—Palpitations—Temozolomide—melanoma	0.00198	0.00404	CcSEcCtD
Nitroglycerin—Paraesthesia—Bleomycin—melanoma	0.00195	0.00397	CcSEcCtD
Nitroglycerin—Dyspnoea—Bleomycin—melanoma	0.00193	0.00395	CcSEcCtD
Nitroglycerin—Confusional state—Carmustine—melanoma	0.00191	0.00389	CcSEcCtD
Nitroglycerin—Infestation NOS—Docetaxel—melanoma	0.00191	0.00389	CcSEcCtD
Nitroglycerin—Infestation—Docetaxel—melanoma	0.00191	0.00389	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0019	0.00387	CcSEcCtD
Nitroglycerin—Infection—Carmustine—melanoma	0.00188	0.00384	CcSEcCtD
Nitroglycerin—Stomatitis—Docetaxel—melanoma	0.00186	0.00379	CcSEcCtD
Nitroglycerin—Tachycardia—Carmustine—melanoma	0.00185	0.00377	CcSEcCtD
Nitroglycerin—Confusional state—Temozolomide—melanoma	0.00185	0.00376	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Temozolomide—melanoma	0.00183	0.00373	CcSEcCtD
Nitroglycerin—Infection—Temozolomide—melanoma	0.00182	0.00371	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—BSG—melanoma	0.00181	0.00913	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—BSG—melanoma	0.00181	0.00913	CbGpPWpGaD
Nitroglycerin—Nervous system disorder—Temozolomide—melanoma	0.0018	0.00366	CcSEcCtD
Nitroglycerin—Feeling abnormal—Bleomycin—melanoma	0.00179	0.00365	CcSEcCtD
Nitroglycerin—Skin disorder—Temozolomide—melanoma	0.00178	0.00363	CcSEcCtD
Nitroglycerin—Hypotension—Carmustine—melanoma	0.00177	0.00361	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Temozolomide—melanoma	0.00177	0.00361	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—IFNA5—melanoma	0.00175	0.00884	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IFNA5—melanoma	0.00175	0.00884	CbGpPWpGaD
Nitroglycerin—ALDH2—Tryptophan metabolism—MDM2—melanoma	0.00173	0.00877	CbGpPWpGaD
Nitroglycerin—Urticaria—Bleomycin—melanoma	0.00172	0.00352	CcSEcCtD
Nitroglycerin—Rhinitis—Docetaxel—melanoma	0.00172	0.0035	CcSEcCtD
Nitroglycerin—Body temperature increased—Bleomycin—melanoma	0.00172	0.0035	CcSEcCtD
Nitroglycerin—Paraesthesia—Carmustine—melanoma	0.0017	0.00347	CcSEcCtD
Nitroglycerin—Pharyngitis—Docetaxel—melanoma	0.0017	0.00347	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—FLNA—melanoma	0.0017	0.00859	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—FLNA—melanoma	0.0017	0.00859	CbGpPWpGaD
Nitroglycerin—Dyspnoea—Carmustine—melanoma	0.00169	0.00344	CcSEcCtD
Nitroglycerin—Oedema peripheral—Docetaxel—melanoma	0.00169	0.00344	CcSEcCtD
Nitroglycerin—Somnolence—Carmustine—melanoma	0.00168	0.00343	CcSEcCtD
Nitroglycerin—Feeling abnormal—Dactinomycin—melanoma	0.00167	0.0034	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Dactinomycin—melanoma	0.00165	0.00337	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00165	0.00835	CbGpPWpGaD
Nitroglycerin—Visual impairment—Docetaxel—melanoma	0.00165	0.00337	CcSEcCtD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—PRKCA—melanoma	0.00165	0.00835	CbGpPWpGaD
Nitroglycerin—Paraesthesia—Temozolomide—melanoma	0.00164	0.00335	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Carmustine—melanoma	0.00164	0.00333	CcSEcCtD
Nitroglycerin—Dyspnoea—Temozolomide—melanoma	0.00163	0.00333	CcSEcCtD
Nitroglycerin—Somnolence—Temozolomide—melanoma	0.00163	0.00332	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—BSG—melanoma	0.00161	0.00814	CbGpPWpGaD
Nitroglycerin—Abdominal pain—Dactinomycin—melanoma	0.0016	0.00326	CcSEcCtD
Nitroglycerin—Body temperature increased—Dactinomycin—melanoma	0.0016	0.00326	CcSEcCtD
Nitroglycerin—Hypersensitivity—Bleomycin—melanoma	0.0016	0.00326	CcSEcCtD
Nitroglycerin—Flushing—Docetaxel—melanoma	0.00159	0.00324	CcSEcCtD
Nitroglycerin—Cardiac disorder—Docetaxel—melanoma	0.00159	0.00324	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Temozolomide—melanoma	0.00158	0.00322	CcSEcCtD
Nitroglycerin—Feeling abnormal—Carmustine—melanoma	0.00156	0.00318	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—IFNA5—melanoma	0.00156	0.00788	CbGpPWpGaD
Nitroglycerin—Asthenia—Bleomycin—melanoma	0.00156	0.00317	CcSEcCtD
Nitroglycerin—Angiopathy—Docetaxel—melanoma	0.00155	0.00317	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Carmustine—melanoma	0.00155	0.00316	CcSEcCtD
Nitroglycerin—Immune system disorder—Docetaxel—melanoma	0.00155	0.00316	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Docetaxel—melanoma	0.00154	0.00315	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—CLU—melanoma	0.00154	0.00776	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CLU—melanoma	0.00154	0.00776	CbGpPWpGaD
Nitroglycerin—Pruritus—Bleomycin—melanoma	0.00154	0.00313	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—CYP17A1—melanoma	0.00153	0.00776	CbGpPWpGaD
Nitroglycerin—Arrhythmia—Docetaxel—melanoma	0.00153	0.00312	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—FLNA—melanoma	0.00151	0.00765	CbGpPWpGaD
Nitroglycerin—Feeling abnormal—Temozolomide—melanoma	0.00151	0.00308	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—RHOB—melanoma	0.0015	0.0076	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—RHOB—melanoma	0.0015	0.0076	CbGpPWpGaD
Nitroglycerin—Mental disorder—Docetaxel—melanoma	0.0015	0.00306	CcSEcCtD
Nitroglycerin—Abdominal pain—Carmustine—melanoma	0.0015	0.00305	CcSEcCtD
Nitroglycerin—Body temperature increased—Carmustine—melanoma	0.0015	0.00305	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Temozolomide—melanoma	0.0015	0.00305	CcSEcCtD
Nitroglycerin—Erythema—Docetaxel—melanoma	0.00149	0.00304	CcSEcCtD
Nitroglycerin—Hypersensitivity—Dactinomycin—melanoma	0.00149	0.00304	CcSEcCtD
Nitroglycerin—Urticaria—Temozolomide—melanoma	0.00145	0.00297	CcSEcCtD
Nitroglycerin—Asthenia—Dactinomycin—melanoma	0.00145	0.00296	CcSEcCtD
Nitroglycerin—Body temperature increased—Temozolomide—melanoma	0.00145	0.00295	CcSEcCtD
Nitroglycerin—Abdominal pain—Temozolomide—melanoma	0.00145	0.00295	CcSEcCtD
Nitroglycerin—Hypersensitivity—Carmustine—melanoma	0.0014	0.00285	CcSEcCtD
Nitroglycerin—Vomiting—Bleomycin—melanoma	0.00138	0.00281	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—CLU—melanoma	0.00137	0.00692	CbGpPWpGaD
Nitroglycerin—Rash—Bleomycin—melanoma	0.00137	0.00279	CcSEcCtD
Nitroglycerin—Dermatitis—Bleomycin—melanoma	0.00137	0.00279	CcSEcCtD
Nitroglycerin—Asthenia—Carmustine—melanoma	0.00136	0.00277	CcSEcCtD
Nitroglycerin—Hypersensitivity—Temozolomide—melanoma	0.00135	0.00275	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—RAC2—melanoma	0.00135	0.00681	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—RAC2—melanoma	0.00135	0.00681	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—RHOB—melanoma	0.00134	0.00677	CbGpPWpGaD
Nitroglycerin—Syncope—Docetaxel—melanoma	0.00134	0.00273	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—VEGFC—melanoma	0.00133	0.0067	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—VEGFC—melanoma	0.00133	0.0067	CbGpPWpGaD
Nitroglycerin—Palpitations—Docetaxel—melanoma	0.00132	0.00269	CcSEcCtD
Nitroglycerin—Asthenia—Temozolomide—melanoma	0.00131	0.00268	CcSEcCtD
Nitroglycerin—Loss of consciousness—Docetaxel—melanoma	0.00131	0.00267	CcSEcCtD
Nitroglycerin—Pruritus—Temozolomide—melanoma	0.0013	0.00264	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—CYP1B1—melanoma	0.00129	0.00653	CbGpPWpGaD
Nitroglycerin—Nausea—Bleomycin—melanoma	0.00129	0.00263	CcSEcCtD
Nitroglycerin—Vomiting—Dactinomycin—melanoma	0.00129	0.00262	CcSEcCtD
Nitroglycerin—Rash—Dactinomycin—melanoma	0.00128	0.0026	CcSEcCtD
Nitroglycerin—ALDH2—Neuronal System—GRIN2A—melanoma	0.00127	0.0064	CbGpPWpGaD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00126	0.00257	CcSEcCtD
Nitroglycerin—Dizziness—Carmustine—melanoma	0.00125	0.00255	CcSEcCtD
Nitroglycerin—Confusional state—Docetaxel—melanoma	0.00123	0.0025	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Docetaxel—melanoma	0.00122	0.00248	CcSEcCtD
Nitroglycerin—Dizziness—Temozolomide—melanoma	0.00121	0.00247	CcSEcCtD
Nitroglycerin—Infection—Docetaxel—melanoma	0.00121	0.00247	CcSEcCtD
Nitroglycerin—Vomiting—Carmustine—melanoma	0.0012	0.00246	CcSEcCtD
Nitroglycerin—Nausea—Dactinomycin—melanoma	0.0012	0.00245	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—RAC2—melanoma	0.0012	0.00607	CbGpPWpGaD
Nitroglycerin—Shock—Docetaxel—melanoma	0.0012	0.00244	CcSEcCtD
Nitroglycerin—Rash—Carmustine—melanoma	0.00119	0.00244	CcSEcCtD
Nitroglycerin—Nervous system disorder—Docetaxel—melanoma	0.00119	0.00243	CcSEcCtD
Nitroglycerin—Dermatitis—Carmustine—melanoma	0.00119	0.00243	CcSEcCtD
Nitroglycerin—Tachycardia—Docetaxel—melanoma	0.00119	0.00242	CcSEcCtD
Nitroglycerin—Headache—Carmustine—melanoma	0.00119	0.00242	CcSEcCtD
Nitroglycerin—Skin disorder—Docetaxel—melanoma	0.00118	0.00241	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—VEGFC—melanoma	0.00118	0.00597	CbGpPWpGaD
Nitroglycerin—Vomiting—Temozolomide—melanoma	0.00116	0.00237	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—F2R—melanoma	0.00116	0.00588	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—F2R—melanoma	0.00116	0.00588	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—SPARC—melanoma	0.00116	0.00588	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—SPARC—melanoma	0.00116	0.00588	CbGpPWpGaD
Nitroglycerin—Rash—Temozolomide—melanoma	0.00115	0.00235	CcSEcCtD
Nitroglycerin—Dermatitis—Temozolomide—melanoma	0.00115	0.00235	CcSEcCtD
Nitroglycerin—Headache—Temozolomide—melanoma	0.00115	0.00234	CcSEcCtD
Nitroglycerin—Hypotension—Docetaxel—melanoma	0.00114	0.00232	CcSEcCtD
Nitroglycerin—Nausea—Carmustine—melanoma	0.00113	0.00229	CcSEcCtD
Nitroglycerin—Paraesthesia—Docetaxel—melanoma	0.00109	0.00223	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—HSPA5—melanoma	0.00109	0.00551	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—HSPA5—melanoma	0.00109	0.00551	CbGpPWpGaD
Nitroglycerin—Nausea—Temozolomide—melanoma	0.00109	0.00222	CcSEcCtD
Nitroglycerin—Dyspnoea—Docetaxel—melanoma	0.00109	0.00221	CcSEcCtD
Nitroglycerin—Somnolence—Docetaxel—melanoma	0.00108	0.00221	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—GNA11—melanoma	0.00106	0.00538	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—GAB2—melanoma	0.00106	0.00538	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—GNA11—melanoma	0.00106	0.00538	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—GAB2—melanoma	0.00106	0.00538	CbGpPWpGaD
Nitroglycerin—Gastrointestinal disorder—Docetaxel—melanoma	0.00105	0.00214	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—F2R—melanoma	0.00104	0.00525	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—SPARC—melanoma	0.00104	0.00525	CbGpPWpGaD
Nitroglycerin—Feeling abnormal—Docetaxel—melanoma	0.001	0.00205	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—HDAC2—melanoma	0.001	0.00506	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—HDAC2—melanoma	0.001	0.00506	CbGpPWpGaD
Nitroglycerin—Gastrointestinal pain—Docetaxel—melanoma	0.000995	0.00203	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—GNAQ—melanoma	0.000989	0.005	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—GNAQ—melanoma	0.000989	0.005	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—CD44—melanoma	0.000989	0.005	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITGA4—melanoma	0.000989	0.005	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CD44—melanoma	0.000989	0.005	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ITGA4—melanoma	0.000989	0.005	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IFNB1—melanoma	0.000982	0.00497	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—IFNB1—melanoma	0.000982	0.00497	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—HSPA5—melanoma	0.000971	0.00491	CbGpPWpGaD
Nitroglycerin—Body temperature increased—Docetaxel—melanoma	0.000962	0.00196	CcSEcCtD
Nitroglycerin—Abdominal pain—Docetaxel—melanoma	0.000962	0.00196	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—IFNA1—melanoma	0.000958	0.00485	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—IFNA1—melanoma	0.000958	0.00485	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—GAB2—melanoma	0.000949	0.0048	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—GNA11—melanoma	0.000949	0.0048	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—SYK—melanoma	0.00093	0.0047	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—SYK—melanoma	0.00093	0.0047	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITGAV—melanoma	0.000913	0.00462	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ITGAV—melanoma	0.000913	0.00462	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—AKT3—melanoma	0.000913	0.00462	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—AKT3—melanoma	0.000913	0.00462	CbGpPWpGaD
Nitroglycerin—Hypersensitivity—Docetaxel—melanoma	0.000897	0.00183	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—IFNA2—melanoma	0.000892	0.00451	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—HDAC2—melanoma	0.000892	0.00451	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IFNA2—melanoma	0.000892	0.00451	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—GNAQ—melanoma	0.000882	0.00446	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ITGA4—melanoma	0.000882	0.00446	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CD44—melanoma	0.000882	0.00446	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—IFNB1—melanoma	0.000875	0.00443	CbGpPWpGaD
Nitroglycerin—Asthenia—Docetaxel—melanoma	0.000873	0.00178	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—PRKCA—melanoma	0.000868	0.00439	CbGpPWpGaD
Nitroglycerin—Pruritus—Docetaxel—melanoma	0.000861	0.00176	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ACER3—melanoma	0.000861	0.00435	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—IFNA1—melanoma	0.000854	0.00432	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—NFKB1—melanoma	0.000852	0.00431	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ITGB1—melanoma	0.000829	0.00419	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITGB1—melanoma	0.000829	0.00419	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—SYK—melanoma	0.000829	0.00419	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ITGAV—melanoma	0.000814	0.00412	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—AKT3—melanoma	0.000814	0.00412	CbGpPWpGaD
Nitroglycerin—Dizziness—Docetaxel—melanoma	0.000805	0.00164	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—IFNA2—melanoma	0.000795	0.00402	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—UGT2B10—melanoma	0.000788	0.00398	CbGpPWpGaD
Nitroglycerin—Vomiting—Docetaxel—melanoma	0.000774	0.00158	CcSEcCtD
Nitroglycerin—Rash—Docetaxel—melanoma	0.000768	0.00157	CcSEcCtD
Nitroglycerin—Dermatitis—Docetaxel—melanoma	0.000767	0.00156	CcSEcCtD
Nitroglycerin—Headache—Docetaxel—melanoma	0.000763	0.00156	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—HGF—melanoma	0.000758	0.00384	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—HGF—melanoma	0.000758	0.00384	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—CSF2—melanoma	0.00075	0.00379	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CSF2—melanoma	0.00075	0.00379	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ITGB1—melanoma	0.000739	0.00374	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HS3ST5—melanoma	0.000732	0.0037	CbGpPWpGaD
Nitroglycerin—Nausea—Docetaxel—melanoma	0.000723	0.00147	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—ITGB3—melanoma	0.000719	0.00364	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PRKCA—melanoma	0.000719	0.00364	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITGB3—melanoma	0.000719	0.00364	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PRKCA—melanoma	0.000719	0.00364	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—HGF—melanoma	0.000676	0.00342	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CSF2—melanoma	0.000668	0.00338	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—RAC1—melanoma	0.000667	0.00337	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—RAC1—melanoma	0.000667	0.00337	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—PRKCA—melanoma	0.000665	0.00336	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—MMP1—melanoma	0.000645	0.00326	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—MMP1—melanoma	0.000645	0.00326	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PRKCA—melanoma	0.000641	0.00324	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ITGB3—melanoma	0.000641	0.00324	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—BRAF—melanoma	0.000639	0.00323	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CDK2—melanoma	0.000633	0.0032	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—CDK2—melanoma	0.000633	0.0032	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—RAC1—melanoma	0.000594	0.003	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—FN1—melanoma	0.000588	0.00298	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—FN1—melanoma	0.000588	0.00298	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—NOS2—melanoma	0.000581	0.00294	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—NOS2—melanoma	0.000581	0.00294	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—MMP1—melanoma	0.000575	0.00291	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CDK2—melanoma	0.000564	0.00285	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CG—melanoma	0.000563	0.00285	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CG—melanoma	0.000563	0.00285	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—EGF—melanoma	0.000557	0.00281	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—EGF—melanoma	0.000557	0.00281	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PLCB4—melanoma	0.000555	0.00281	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—MDM2—melanoma	0.000535	0.00271	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—melanoma	0.000535	0.00271	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—FN1—melanoma	0.000524	0.00265	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SLC6A11—melanoma	0.000522	0.00264	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIP4K2A—melanoma	0.000522	0.00264	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—NOS2—melanoma	0.000518	0.00262	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—IGF1—melanoma	0.000516	0.00261	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IGF1—melanoma	0.000516	0.00261	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—MTAP—melanoma	0.000508	0.00257	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CG—melanoma	0.000502	0.00254	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—EGF—melanoma	0.000496	0.00251	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CD—melanoma	0.000495	0.0025	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CD—melanoma	0.000495	0.0025	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—BRAF—melanoma	0.000489	0.00248	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ALB—melanoma	0.000489	0.00247	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ALB—melanoma	0.000489	0.00247	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—IGF1—melanoma	0.00046	0.00232	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—LUM—melanoma	0.000452	0.00229	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PHGDH—melanoma	0.000452	0.00229	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HPSE—melanoma	0.000444	0.00224	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CD—melanoma	0.000441	0.00223	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ALB—melanoma	0.000436	0.0022	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CUBN—melanoma	0.000435	0.0022	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CB—melanoma	0.000431	0.00218	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CB—melanoma	0.000431	0.00218	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SDHD—melanoma	0.000421	0.00213	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—BSG—melanoma	0.000421	0.00213	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CSPG4—melanoma	0.000421	0.00213	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—MDM2—melanoma	0.00041	0.00207	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GPAM—melanoma	0.000407	0.00206	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IL2—melanoma	0.000396	0.002	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—IL2—melanoma	0.000396	0.002	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CB—melanoma	0.000385	0.00194	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—MAPK1—melanoma	0.000366	0.00185	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—IL2—melanoma	0.000353	0.00179	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PLA2G6—melanoma	0.000346	0.00175	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—VEGFA—melanoma	0.000337	0.0017	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—VEGFA—melanoma	0.000337	0.0017	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—NRAS—melanoma	0.000333	0.00168	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—NRAS—melanoma	0.000333	0.00168	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—MAPK3—melanoma	0.000319	0.00161	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—MAPK3—melanoma	0.000319	0.00161	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—VCAN—melanoma	0.000311	0.00157	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—MAPK1—melanoma	0.000303	0.00153	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—MAPK1—melanoma	0.000303	0.00153	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—VEGFA—melanoma	0.0003	0.00152	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—NRAS—melanoma	0.000296	0.0015	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—HRAS—melanoma	0.000294	0.00149	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—KRAS—melanoma	0.000286	0.00145	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—KRAS—melanoma	0.000286	0.00145	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—MAPK3—melanoma	0.000284	0.00144	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—MAPK1—melanoma	0.00028	0.00142	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—MAPK1—melanoma	0.00027	0.00137	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CA—melanoma	0.000263	0.00133	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CA—melanoma	0.000263	0.00133	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP17A1—melanoma	0.000262	0.00133	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—KRAS—melanoma	0.000255	0.00129	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—TP53—melanoma	0.000254	0.00129	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—TP53—melanoma	0.000254	0.00129	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GNA11—melanoma	0.000248	0.00125	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—HRAS—melanoma	0.000243	0.00123	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—HRAS—melanoma	0.000243	0.00123	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—FASN—melanoma	0.000243	0.00123	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SLC5A5—melanoma	0.000239	0.00121	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CA—melanoma	0.000234	0.00119	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GNAQ—melanoma	0.00023	0.00117	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CD44—melanoma	0.00023	0.00117	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—TP53—melanoma	0.000227	0.00115	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—HRAS—melanoma	0.000225	0.00114	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP1B1—melanoma	0.000221	0.00112	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—HRAS—melanoma	0.000217	0.0011	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—AKT1—melanoma	0.000215	0.00109	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—AKT1—melanoma	0.000215	0.00109	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—AKT1—melanoma	0.000192	0.000969	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ABCB1—melanoma	0.000182	0.00092	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PRKCA—melanoma	0.000167	0.000847	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ERCC2—melanoma	0.000166	0.00084	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CG—melanoma	0.000131	0.000663	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PPARG—melanoma	0.000127	0.00064	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CD—melanoma	0.000115	0.000583	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ALB—melanoma	0.000114	0.000575	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CB—melanoma	0.0001	0.000508	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTGS2—melanoma	9.96e-05	0.000503	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTEN—melanoma	8.68e-05	0.000439	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CA—melanoma	6.13e-05	0.00031	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—AKT1—melanoma	5e-05	0.000253	CbGpPWpGaD
